Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1677824

	registered interest
	date	13/12/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes and Oral Tobacco
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether it is her Department's policy to restrict the future availability of Snus and vapes.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	6853
	answer	answer is ministerial correction date of answer 20/12/2023 answer text <p>The sale of oral tobacco, such as Snus, is banned in the United Kingdom under the Tobacco and Related Products Regulations 2016.</p><p>Vapes are less harmful than smoking because they do not contain tobacco, and therefore can be an effective tool in supporting smoking cessation. Vaping is already estimated to contribute to an extra 50,000 to 70,000 smoking quits per year in England. Ensuring that vapes continue to be available to current adult smokers is vital to reducing smoking rates.</p><p>However, the number of children using vapes has tripled in the past 3 years. To tackle this, the Tobacco and Vapes Bill will introduce measures to restrict the appeal and availability of vapes to children.</p><p>To support this, we recently consulted on a set of proposals to reduce youth vaping, ensuring we get the balance right between protecting our children and supporting adult smokers to quit. We will respond to the consultation in the coming weeks.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 20/12/2023 17:49:18 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1680625

	registered interest
	date	08/01/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Oral Tobacco: Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of high-profile use of snus on young people's health.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	8538
	answer	answer is ministerial correction date of answer 16/01/2024 answer text <p>Snus is banned in the United Kingdom and we have no plans to introduce additional tobacco products to the UK market. Alternative tobacco-free products exist, such as nicotine pouches, which are sometimes referred to as snus. Research suggests that, although nicotine pouch use is low among adults, with 0.26% or 1 in 400 users in Great Britain, it is increasingly popular with younger male audiences. We will continue to monitor the evidence on these products.</p><p>In our recent consultation, Creating a smokefree generation and tackling youth vaping, the Government explored whether further regulatory measures are needed for other nicotine consumer products such as nicotine pouches. The consultation closed on 6 December 2023 and we will publish a consultation response shortly.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 16/01/2024 12:58:33 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1682223

	registered interest
	date	15/01/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help local authorities tackle substance misuse.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	9576
	answer	answer is ministerial correction date of answer 22/01/2024 answer text <p>As part of the Government’s 10-year drug strategy, local authorities are receiving £532 million of additional investment through to 2024/25 to improve drug and alcohol treatment and recovery services. This funding is in addition to the Public Health Grant.</p><p> </p><p>The Department is actively supporting local authorities to develop and implement their local plans for drug and alcohol treatment and are monitoring outcomes through the national outcomes framework. This support includes the Commissioning Quality Standard, published in August 2022, which provides guidance for commissioning effective alcohol and drug treatment and recovery services. The Department also published guidance on Recovery support services and lived experience initiatives to support regions to develop and improve recovery-orientated systems of care, to help people to achieve and sustain recovery. The guidance is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/recovery-support-services-and-lived-experience-initiatives" target="_blank">https://www.gov.uk/government/publications/recovery-support-services-and-lived-experience-initiatives</a></p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 22/01/2024 16:13:58 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1690478

	registered interest
	date	20/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Fluoride: Drinking Water
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what criteria were used to determine the location of water fluoridation schemes.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	14905
	answer	answer is ministerial correction date of answer 28/02/2024 answer text <p>Decisions on existing water fluoridation schemes in England were determined by the relevant National Health Service or local authorities responsible at the time they were introduced, in agreement with the water undertaker and focussed on reducing tooth decay. The Government’s proposal to expand water fluoridation in the North East, subject to a public consultation to begin early this year, is based on large inequalities in oral health, existing feasibility studies, and water company experience operating such schemes.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 28/02/2024 15:22:16 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1670385

	registered interest
	date	15/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Tumours: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether NICE assessments of rare tumour type treatments consider both the failure rate of radiotherapy and the success rate of new treatments.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	2190
	answer	answer is ministerial correction date of answer 20/11/2023 answer text <p>In its evaluations of new health technologies, including for rare diseases, the National Institute for Health and Care Excellence (NICE) takes into account all health-related costs and benefits, including evidence of comparative outcomes against existing treatment options such as radiotherapy. Full details of the process and methods used by NICE in undertaking evaluations are set out in NICE health technology evaluations: the manual, published on the NICE website and available at the following link:</p><p><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nice.org.uk%2Fprocess%2Fpmg36%2Fchapter%2Fintroduction-to-health-technology-evaluation&amp;data=05%7C01%7CMD.Support%40dhsc.gov.uk%7C333109cf26904e79aba608dbe7825f03%7C61278c3091a84c318c1fef4de8973a1c%7C1%7C0%7C638358319347196670%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=hNltwwubSKJyLzQAyiKcpnHhf45seq1SehLv59TkbCo%3D&amp;reserved=0" target="_blank">https://www.nice.org.uk/process/pmg36/chapter/introduction-to-health-technology-evaluation</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/11/2023 16:42:51 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1670388

	registered interest
	date	15/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will take steps to ensure non-stageable cancers are included in the NHS early diagnosis target.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	2191
	answer	answer is ministerial correction date of answer 22/11/2023 answer text <p>The NHS Long Term Plan set an ambition that, by 2028, the proportion of cancers diagnosed at stages 1 and 2 will rise from around half now to three-quarters of cancer patients. Achieving this will mean that, from 2028, 55,000 more people each year will survive their cancer for at least five years after diagnosis. Due to the nature of the ambition, this only includes stageable cancers.</p><p>To find and diagnosed all cancers earlier, NHS England is streamlining cancer pathways to support diagnosis within 28 days by implementing non-symptom specific (NSS) pathways for patients who present with non-specific symptoms that can indicate several cancers, as well as implementing timed cancer pathways.</p><p>Since 2019, cancer alliances have been developing new dedicated urgent diagnostic pathways for these patients so that every cancer patient with concerning, but non-specific symptoms, gets the right tests at the right time in as few visits as possible. By March 2024, the NSS programme will achieve full population coverage across England for non-specific symptom pathways as set out in the 2023/24 NHS Planning Guidance.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/11/2023 11:10:53 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1670389

	registered interest
	date	15/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Commercial Clinical Trials in the UK Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department has taken to implement the (a) significant actions under problem statement 6 and (b) other recommendations of the Lord O'Shaughnessy review of commercial clinical trials.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	2192
	answer	answer is ministerial correction date of answer 21/11/2023 answer text <p>The Government will soon publish a full response to the Lord O’Shaughnessy independent review into commercial clinical trials.</p><p>The response will include an update on progress and implementation of the initial five headline commitments and foundational actions that the Government made in May 2023 as well as all other recommendations in the review.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/11/2023 16:03:12 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1693957

	registered interest
	date	05/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans she has to help improve breast screening uptake.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	17236
	answer	answer is ministerial correction date of answer 12/03/2024 answer text <p>NHS England has developed an internal national plan in collaboration with key stakeholders, to improve uptake within the breast screening programme from 2023 and beyond. This plan will encompass a series of evaluative projects, which are expected to report by April 2024. It is available on the NHS Futures Platform. This is a collaboration platform that empowers everyone working in health and social care to safely connect, share, and learn across boundaries.</p><p>The Government has invested £10 million of funding for the breast screening programme, which provided 28 new breast screening units and nearly 60 upgrades, to be targeted at areas with the greatest challenges of uptake and coverage. This will provide extra capacity for services to recover from the impact of the pandemic, boost uptake of screening in areas where attendance is low, tackle health disparities, and contribute towards higher early diagnosis rates in line with the NHS Long Term Plan.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 12/03/2024 18:02:35 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1145978

	registered interest
	date	25/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	IVF: Single People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the NHS on NHS spending following media reports on 8 September 2019 that the NHS is to review the ban on single women receiving fertility treatment.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	291091
	answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>The level of provision of local health services, including fertility treatment, available to patients is, and has been since the 1990s, a matter for local healthcare commissioners, who must consider the needs and priorities of all their population. Clinical commissioning groups (CCGs) have the current statutory responsibility to commission high quality services that meet the needs of their local population. Decisions about treatment should always be based on patients’ clinical needs.</p><p>If there are concerns about provision of care, it is for NHS England to ensure the CCG is not breaching its statutory responsibility to provide services that meet the needs of the local population. Where performance concerns are identified, NHS England has the ability to exercise formal legal powers to either provide an enhanced support to a CCG, or in rare circumstances to intervene where it is believed that a CCG is failing, or is at risk of failing, to discharge its functions.</p><p>NHS England has advised that the CCGs in south east London have agreed to undertake a rapid review of the NHS South East London’s Treatment Access Policy Document in relation to access criteria for funding in vitro fertilisation (IVF) by the end of November 2019.</p><p>The CCGs have made a public apology for any offence caused by the wording in the Treatment Access Policy Document in relation to single women’s access to IVF treatment and the review document it refers to and agree that this wording is unacceptable.</p><p>The rapid review will also specifically consider issues relating to equality and discrimination in relation to single women. The CCGs will publish the review alongside any changes to the revision of the policy.</p><p>NHS England and NHS Improvement are aware that the CCGs are undertaking a review of the policy, as the body responsible for that policy. All CCG governing bodies were asked to review and approve any changes to the NHS South East London Treatment Access Policy made for 2019/20.</p><p>In taking clinical decisions about fertility treatment and taking account of their public sector equality duty, CCGs should make assessments based on clinical infertility and not on relationship status.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 30/09/2019 16:38:45 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1148258

	registered interest
	date	03/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Fertility: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many NHS Clinical Commissioning Groups offer IVF and other fertility treatments to single women; and how much was spent on such treatment in the last three years.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	294217
	answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>NHS England do not collect data on the number of clinical commissioning groups (CCGs) that offer in vitro fertilisation (IVF) or their expenditure on this specific treatment, although it is estimated that the National Health Services spends approximately £100 million a year on IVF.</p><p>The level of provision of fertility treatment is decided by CCGs, taking into account the needs of their local population. CCGs have a legal duty to have regard to National Institute for Health and Care Excellence guidelines and NHS England and NHS Improvement expects all those involved in commissioning fertility treatment services to be fully aware of their importance. In taking clinical decisions about fertility treatment and taking account of their public sector equality duty, CCGs should make assessments based on clinical infertility and not on relationship status</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 08/10/2019 10:19:27 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4498 label Biography information for Mr Ranil Jayawardena